Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Metastatic Castration-resistant Prostate Cancer (CRPCa)
and you are
over 70
years old
The phase for this study is not defined.
Show me locations

The purpose

This study will assess the impact of the novel oral hormonal agents (abiraterone acetate or enzalutamide) among elderly metastatic prostate cancer patients. This study will assess the influence of treatments on patients' cognitive functions on a longitudinal basis and evaluate the quality of life and the adherence of patients who had or develop cognitive disorders.

Provided treatments

  • Other: neuropsychologic evaluation
  • Other: oncogeriatric evaluation
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02907372. The sponsor of the trial is Centre Francois Baclesse and it is looking for 222 volunteers for the current phase.
Official trial title:
Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer